跳至主要内容
临床试验/NCT01728012
NCT01728012已完成不适用

The Prevalence of Cardiovascular Risk Factors in Patients More Than 10 Years Following Successful Renal Transplant.

Helse Stavanger HF1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Fibroblast growth factor 23 (FGF23)

研究概览

简要总结

Mineral metabolism disturbances occur early during the course of chronic kidney disease and eventually affect most patients. For how long such disturbances persist after a successful renal transplantation is mainly unknown. This study will investigate the prevalence of such disturbances in patients more than 10 years following a successful renal transplantation. The patients will be recruited from an existing registry in Norway.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Registered in the Norwegian Renal Registry
  • Documented elevated iPTH at Tx and 10 weeks post-tx
  • Well functioning transplant 10 years following tx
  • Signed informed consent

排除标准

  • Lack of ability to comply with the protocol
  • Refused written informed consent

结局指标

主要结局

Fibroblast growth factor 23 (FGF23)

时间窗: More than 10 years after successful renal transplantation

To evaluate the long-term effect of a successful renal transplant on this biomarker.

次要结局

  • Klotho(More than 10 years after successful renal transplantation)
  • Intact parathyroid hormone (iPTH)(More than 10 years after successful renal transplantation)
  • Neutrophil gelatinase-associated lipocalin (NGAL)(More than 10 years after successful renal transplantation)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Long-term Cardiovascular Risk Following Successful... | 临床试验